Categories AlphaGraphs, Earnings, Health Care
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today.
Total revenue increased 3% year-over-year to $2.5 billion.
Net income attributable to Biogen Inc. was $266.8 million, or $1.83 per share, compared to $249.7 million, or $1.71 per share, last year. Adjusted EPS grew 17% YoY to $3.44.
For full-year 2025, the company expects total revenue to decline by a mid-single digit percentage at constant currency versus full-year 2024. Adjusted EPS is expected to be $15.25-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Signet Jewelers (SIG) Q4 2025 Earnings fall on lower sales
Signet Jewelers Limited (NYSE: SIG) on Wednesday reported a decrease in adjusted earnings and net sales for the fourth quarter of 2025. Fourth-quarter sales declined 6% to $2.35 billion from
Paychex (PAYX) gears up for Q3 earnings with focus on business expansion
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, is expanding its artificial intelligence capabilities to stay relevant in the evolving HR landscape, while also increasing
What to look for when KB Home (KBH) reports Q1 2025 earnings results
Shares of KB Home (NYSE: KBH) dropped 1% on Tuesday. The stock has dropped 14% over the past three months. The homebuilder is slated to report its first quarter 2025
